{"id":246108,"date":"2012-07-31T22:18:20","date_gmt":"2012-07-31T22:18:20","guid":{"rendered":"http:\/\/www.eugenesis.com\/pathgroup-unveils-a-new-look-continues-to-expand-footprint\/"},"modified":"2012-07-31T22:18:20","modified_gmt":"2012-07-31T22:18:20","slug":"pathgroup-unveils-a-new-look-continues-to-expand-footprint","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/pathgroup-unveils-a-new-look-continues-to-expand-footprint.php","title":{"rendered":"PathGroup Unveils a New Look; Continues to Expand Footprint"},"content":{"rendered":"<p><p>    BRENTWOOD, Tenn., July 31, 2012 \/PRNewswire\/    --PathGroup, a leading provider of anatomic,    clinical and molecular pathology services, launched an updated    website today, <a href=\"http:\/\/www.pathgroup.com.The\" rel=\"nofollow\">http:\/\/www.pathgroup.com.The<\/a> new site comes    after PathGroup unveiled, earlier this year, a new brand    identity to include a revised logo and tagline; illustrating a    contemporary identity and vision as the company adapts in an    ever-changing healthcare environment. The redesigned site    further demonstrates PathGroup's industry expertise, breadth of    capabilities, and will serve as a resource for customers and    patients.  <\/p>\n<p>    (Logo: <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20120731\/CL49477LOGO\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20120731\/CL49477LOGO<\/a>    )  <\/p>\n<p>    \"Launching a refreshed identity as we expand into new markets    will enable us to effectively communicate the central focus of    PathGroup  to exceed the expectations of our clients and their    patients,\" said Richard Halstead, Senior Vice President and    Chief Marketing Officer for PathGroup. \"Although this is    a new look for PathGroup, the core foundation of the    organization remains focused on providing industry leading    anatomic, clinical and molecular pathology services.\"  <\/p>\n<p>    As one of the largest, private providers of pathology    services in the United States, PathGroup continues to    expand its service offering through organic growth initiatives    and strategic merger and acquisitions. With over 45 years    of experience providing the highest quality services, PathGroup    has over 700 employees and more than 70 pathologists    representing every sub-specialty. The company's longevity can    be attributed to consistently exceeding the expectations of    clients and patients. Direct access to PathGroup's team of    dedicated pathologists is a central focus of the organization,    leading to better client relations and ultimately better    patient outcomes. This new identity and user-friendly    website are reflective of that open culture.  <\/p>\n<p>    \"This is an exciting time for PathGroup and the clients we    provide service to,\" said Ben Davis, MD, PathGroup's Chairman,    President and CEO.\"We will continue to provide high    quality care and evolve our organization as the healthcare    industry changes.Our goal is to meet the needs of those    we provide services for, with a physician centered approach    that is keenly focused on driving better patient outcomes.    Staying at the forefront of advances in laboratory medicine is    a critical component.\"  <\/p>\n<p>    About PathGroup Founded in 1965, PathGroup has    evolved into a premier provider of anatomic, clinical and    molecular pathology services.Privately held and physician    centric, PathGroup works seamlessly with customers to provide    superior diagnostic services  a vital link in the cycle of    patient relationships. PathGroup uses the latest in    proprietary and industry standard technology to deliver fast,    accurate results.The company provides clients with the    highest quality of services available, consistently exceeding    the expectations of physicians, employees, payers and most    importantly, patients. One Lab; Total Service.For    more information, visit <a href=\"http:\/\/www.pathgroup.com\" rel=\"nofollow\">http:\/\/www.pathgroup.com<\/a>  <\/p>\n<\/p>\n<p>Continue reading here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/pathgroup-unveils-look-continues-expand-173200422.html;_ylt=A2KJ3CSrWRhQJ0gA8MX_wgt.\" title=\"PathGroup Unveils a New Look; Continues to Expand Footprint\">PathGroup Unveils a New Look; Continues to Expand Footprint<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BRENTWOOD, Tenn., July 31, 2012 \/PRNewswire\/ --PathGroup, a leading provider of anatomic, clinical and molecular pathology services, launched an updated website today, <a href=\"http:\/\/www.pathgroup.com.The\" rel=\"nofollow\">http:\/\/www.pathgroup.com.The<\/a> new site comes after PathGroup unveiled, earlier this year, a new brand identity to include a revised logo and tagline; illustrating a contemporary identity and vision as the company adapts in an ever-changing healthcare environment. The redesigned site further demonstrates PathGroup's industry expertise, breadth of capabilities, and will serve as a resource for customers and patients <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/pathgroup-unveils-a-new-look-continues-to-expand-footprint.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-246108","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246108"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=246108"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=246108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=246108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=246108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}